COCHNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as COCHW

Envoy Medical, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026

$0.65−0.01 (-2.10%)

Close on Oct 19, 2026

Market cap: $68.04M
P/E (TTM): –
Dividend yield: –

Envoy Medical, Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Stock-Based Compensation	0.66	0.56	1.58	0	–
Deferred Income Taxes	–	2.59	5.78	0.65	–
Change in Accounts Receivable	0.00	0.03	-0.03	0.05	–
Change in Inventory	0.13	-0.38	-0.01	-0.19	–
Change in Accounts Payable	1.39	-0.02	0.55	0.34	0.62
Operating Cash Flow	-18	-18	-17	-8.81	-3.24
Capital Expenditures	-0.18	-0.98	-0.15	-0.22	–
Investing Cash Flow	-0.18	-0.98	-0.15	-0.22	-425
Dividends Paid	-1.82	-2.45	–	–	–
Stock Issued	0.41	–	0.11	–	–
Financing Cash Flow	17	20	21	8.09	428
Foreign Exchange Rate Adjustments	0.00	-0.01	0.00	-0.01	–
Net Change in Cash	-1.74	1.26	4.04	-0.94	0.12
Free Cash Flow	-18	-19	-17	-9.02	–
Interest Paid	0.04	0.04	0.03	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: -385.5%
Operating margin: -11411.1%
Net margin: -11304.8%
Return on equity, FY2025: 153.3%

Financial strength

Current ratio: 1.73
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 155.8%

Valuation

P/E ratio: –
Price to sales: 328.70
Price to book: 20.60
Dividend yield: –